4.71
Salarius Pharmaceuticals Inc (SLRX) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
|
43.82%
0.9656
|
1.7187 | 1.4887 | 1.0065 | 1.4675 |
Operating Income/Loss |
43.82%
-0.9656
|
-1.7187 | -1.4887 | -1.0065 | -1.4675 |
Income/Loss From Continuing Operations Before Tax |
43.97%
-0.9578
|
-1.7095 | -1.4639 | -0.9721 | -1.4244 |
Income/Loss From Continuing Operations After Tax |
43.97%
-0.9578
|
-1.7095 | -1.4639 | -0.9721 | -1.4244 |
|
43.97%
-0.9578
|
-1.7095 | -1.4639 | -0.9721 | -1.4244 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
27.58%
2.1229
|
1.6639 | 0.1608 | 1.2819 | 0.6004 |
Diluted Average Shares |
27.58%
2.1229
|
1.6639 | 0.1608 | 1.2819 | 0.6004 |
Basic Earnings Per Share |
56.31%
-0.45
|
-1.03 | -0.66 | -0.76 | -2.37 |
Diluted Earnings Per Share |
56.31%
-0.45
|
-1.03 | -0.66 | -0.76 | -2.37 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):